Published in Int J Exp Pathol on April 01, 1992
Vascular complications after splenectomy for hematologic disorders. Blood (2009) 1.89
Overexpression of glucose-6-phosphate dehydrogenase is associated with lipid dysregulation and insulin resistance in obesity. Mol Cell Biol (2005) 1.24
Cholesterol metabolism during the growth of a rat ascites hepatoma (Yoshida AH-130). Br J Cancer (1992) 1.06
Relationship between serum cholesterol and indices of erythrocytes and platelets in the US population. J Lipid Res (2013) 0.85
Cell cholesterol esters and high-density lipoprotein plasma levels during liver hyperplasia in choline-fed male and female rats. Int J Exp Pathol (2000) 0.75
Red algal bromophenols as glucose 6-phosphate dehydrogenase inhibitors. Mar Drugs (2013) 0.75
Cancer incidence by levels of cholesterol. JAMA (1981) 2.42
The relationship of serum cholesterol to the incidence of cancer in Evans County, Georgia. J Chronic Dis (1980) 1.31
Hepatic cholesterol in lead nitrate induced liver hyperplasia. Chem Biol Interact (1984) 1.26
Incidence of insulin-dependent diabetes mellitus among Sardinian-heritage children born in Lazio region, Italy. Lancet (1997) 3.32
Long-term, near-total liver replacement by transplantation of isolated hepatocytes in rats treated with retrorsine. Am J Pathol (1998) 2.62
Circulating haemopoietic and endothelial progenitor cells are decreased in COPD. Eur Respir J (2006) 2.05
Liposomal amphotericin B does not induce nephrotoxicity or renal function impairment in premature neonates. Early Hum Dev (2012) 2.02
High incidence of type I diabetes in Sardinia. Lancet (1991) 1.45
Diminished response to cytotoxic therapy in G-6-PD deficiency. Lancet (1980) 1.39
Neural correlates of cognitive control of reaching movements in the dorsal premotor cortex of rhesus monkeys. J Neurophysiol (2011) 1.29
Liver regeneration in response to partial hepatectomy in rats treated with retrorsine: a kinetic study. J Hepatol (1999) 1.28
Observation of associated near-side and away-side long-range correlations in sqrt[s(NN)]=5.02 TeV proton-lead collisions with the ATLAS detector. Phys Rev Lett (2013) 1.27
Hepatic cholesterol in lead nitrate induced liver hyperplasia. Chem Biol Interact (1984) 1.26
Cholesterol content in tumor tissues is inversely associated with high-density lipoprotein cholesterol in serum in patients with gastrointestinal cancer. Cancer (1994) 1.20
Search for dark matter candidates and large extra dimensions in events with a photon and missing transverse momentum in pp collision data at sqrt[s]=7 TeV with the ATLAS detector. Phys Rev Lett (2013) 1.19
Massive liver replacement by transplanted hepatocytes in the absence of exogenous growth stimuli in rats treated with retrorsine. Am J Pathol (2001) 1.17
Search for a supersymmetric partner to the top quark in final states with jets and missing transverse momentum at sqrt[s] = 7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.13
A growth-constrained environment drives tumor progression invivo. Proc Natl Acad Sci U S A (2001) 1.11
Occurrence of cell death (apoptosis) during the involution of liver hyperplasia. Lab Invest (1985) 1.09
Choline-deficiency fatty liver: impaired release of hepatic triglycerides. J Lipid Res (1968) 1.08
Serum lipoproteins and cancer. Nutr Metab Cardiovasc Dis (2008) 1.08
Cholesterol metabolism during the growth of a rat ascites hepatoma (Yoshida AH-130). Br J Cancer (1992) 1.06
Cell deletion by apoptosis during regression of renal hyperplasia. Am J Pathol (1989) 0.98
Altered pattern of lipid metabolism in patients with lung cancer. Oncology (1992) 0.98
Dyschromatopsia in diabetes mellitus and its relation to metabolic control. Diabetes Care (1983) 0.98
Transplantation of normal hepatocytes modulates the development of chronic liver lesions induced by a pyrrolizidine alkaloid, lasiocarpine. Carcinogenesis (1995) 0.97
Hepatic glucose-6-phosphate dehydrogenase, cholesterogenesis, and serum lipoproteins in liver regeneration after partial hepatectomy. Exp Mol Pathol (1986) 0.97
Cell proliferation and promotion of rat liver carcinogenesis: different effect of hepatic regeneration and mitogen induced hyperplasia on the development of enzyme-altered foci. Carcinogenesis (1990) 0.96
Cholesterol esters as growth regulators of lymphocytic leukaemia cells. Cell Prolif (2011) 0.91
Glucose-6-phosphate dehydrogenase deficiency protects against coronary heart disease. J Inherit Metab Dis (2008) 0.91
Comparison of the seasonal pattern in the clinical onset of IDDM in Finland and Sardinia. Diabetes Care (1998) 0.90
Total and HDL cholesterol in human hematologic neoplasms. Int J Hematol (1991) 0.90
Liver cell proliferation induced by a single dose of lead nitrate. Am J Pathol (1983) 0.89
Sexually differentiated response to choline in choline deficiency and ethionine intoxication. Int J Exp Pathol (1995) 0.88
Metabolomics in neonatology and pediatrics. Clin Biochem (2011) 0.88
Acute nephrotoxicity of NSAID from the foetus to the adult. Eur Rev Med Pharmacol Sci (2011) 0.87
Variations of serum lipoproteins during cell proliferation induced by lead nitrate. Exp Mol Pathol (1989) 0.87
Role of cholesterol synthesis and esterification in the growth of CEM and MOLT4 lymphoblastic cells. Biochem J (1997) 0.86
Choline enhances acetylaminofluorene promotion of liver carcinogenesis in female but not in male rats. Carcinogenesis (1992) 0.86
Acinar cell carcinoma of rat pancreas: regulation of cholesterol esterification. Br J Cancer (1986) 0.86
G6PD activity and gene expression in leukemic cells from G6PD-deficient subjects. Cancer Lett (1999) 0.84
Inhibition of fatty acid oxidation by biguanides: implications for metabolic physiopathology. Adv Lipid Res (1974) 0.84
Further evidence that mitogen-induced cell proliferation does not support the formation of enzyme-altered islands in rat liver by carcinogens. Carcinogenesis (1989) 0.84
Changes in serum and hepatic cholesterol in lead-induced liver hyperplasia. Toxicol Pathol (1984) 0.83
Cell growth and cholesterol metabolism in human glucose-6-phosphate dehydrogenase deficient lymphomononuclear cells. Cell Prolif (2002) 0.83
Clinical remission is associated with restoration of normal high-density lipoprotein cholesterol levels in children with malignancies. Clin Sci (Lond) (1995) 0.83
Cell proliferation in rat kidney induced by 1,2-dibromoethane. Toxicol Lett (1987) 0.83
Cholesterol and phospholipid composition of mitochondria and microsomes isolated from morris hepatoma 5123 and rat liver. FEBS Lett (1973) 0.83
A novel variant of lysosomal acid lipase (Leu336-->Pro) associated with acid lipase deficiency and cholesterol ester storage disease. Arterioscler Thromb Vasc Biol (1995) 0.83
Sexual dimorphism in the regulation of cell turnover during liver hyperplasia. Chem Biol Interact (1995) 0.83
Labelling of liver and plasma lecithins after injection of 1-2-14C-2-demethylaminoethanol and 14C-L-methionine-methyl to choline deficient rats. Lipids (1969) 0.83
Viruses and marine pollution. Mar Pollut Bull (2003) 0.82
Transient inhibition by orotic acid does not abolish the in vivo response of rat hepatocytes to a direct mitogen, lead nitrate. J Hepatol (1997) 0.82
The enhancing effect of fasting/refeeding on the growth of nodules selectable by the resistant hepatocyte model in rat liver. Carcinogenesis (1995) 0.81
MDR1 gene expression in normal and atherosclerotic human arteries(1). J Vasc Res (1999) 0.81
MDR1, cholesterol certification and cell growth: a comparative study in normal and multidrug-resistant KB cell lines. Cell Mol Life Sci (2000) 0.81
The resistance phenotype in the development and treatment of cancer. Lancet Oncol (2000) 0.81
Effect of fasting/refeeding on the incidence of chemically induced hepatocellular carcinoma in the rat. Carcinogenesis (1999) 0.81
Protein kinase C isozyme pattern in liver hyperplasia. Biochem Biophys Res Commun (1994) 0.81
Human salmonellosis transmitted by a domestic turtle. Eur J Epidemiol (1992) 0.81
Measurement of Z boson production in Pb-Pb collisions at sqrt[s(NN)]=2.76 TeV with the ATLAS detector. Phys Rev Lett (2013) 0.81
Serum lipoprotein profile in the Mediterranean variant of glucose-6-phosphate dehydrogenase deficiency. Eur J Epidemiol (1992) 0.81
Chronic mitoinhibition during promotion of hepatocarcinogenesis. Dig Dis Sci (1991) 0.80
Nenatal drug induced nephrotoxicity : old and next generation biomarkers for early detection and management of neonatal drug-induced nephrotoxicity, with special emphasis on uNGAL and on metabolomics. Curr Med Chem (2012) 0.80
Lipid metabolism and molecular changes in normal and atherosclerotic vessels. Eur J Vasc Endovasc Surg (2001) 0.80
Failure of mitogen-induced cell proliferation to achieve initiation of rat liver carcinogenesis. Carcinogenesis (1987) 0.80
New insights into the epidemiology of type 1 diabetes in Mediterranean countries. Diabetes Metab Res Rev (1999) 0.80
Mechanisms of the enhanced liver carcinogenesis by choline in female rats: delay in liver growth after partial hepatectomy and stimulation of 2-AAF mitoinhibition. Carcinogenesis (1992) 0.80
Hexose monophosphate shunt and cholesterol synthesis in the diabetic and fasting states. Exp Mol Pathol (1985) 0.80
Early exposure to restraint stress enhances chemical carcinogenesis in rat liver. Cancer Lett (2000) 0.80
Serum lipoproteins during bone marrow hyperplasia after phenylhydrazine administration in rats. Int J Exp Pathol (1990) 0.80
Hexose monophosphate shunt and cholesterogenesis in lead-induced kidney hyperplasia. Chem Biol Interact (1987) 0.80
Metformin and fatty acids. Diabetes Care (1999) 0.80
Effects of the CCl 4 -cycloheximide interaction on protein synthesis and lipid metabolism in rat liver. Biochem Pharmacol (1971) 0.80
Differential effects of choline administration on liver microsomes of female and male rats. Exp Mol Pathol (1978) 0.80